Perospirone for treatment of dissociative identity disorder

Psychiatry and Clinical Neurosciences

Volumn 59, Issue 5, 2005, Pages 624-

  Okugawa, Gaku ^a   Nobuhara, Kenji ^a   Kitashiro, Mami ^a   Kinoshita, Toshihiko ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PEROSPIRONE;

ADULT; ANAMNESIS; ANXIETY; AUDITORY HALLUCINATION; CASE REPORT; CLINICAL FEATURE; FEMALE; HUMAN; LETTER; MULTIPLE PERSONALITY; OUTPATIENT CARE;

ADULT; ANTIPSYCHOTIC AGENTS; ANXIETY; FEMALE; HALLUCINATIONS; HUMANS; INDOLES; MULTIPLE PERSONALITY DISORDER; THIAZOLES;

EID: 28844485079     PISSN: 13231316     EISSN: 14401819     Source Type: Journal    
DOI: 10.1111/j.1440-1819.2005.01427.x     Document Type: Letter

References (3)

1. Ishibashi T, Ohno Y. Perospirone hydrochloride: the novel atypical antipsychotic agent with high affinities for 5-HT2, D2 and 5-HT1 receptors. Biogenic Amines 2004; 18: 307-317.
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn, text revised. American Psychiatric Association, Washington DC, 2000.
3. Gardner CR. Potential use of drugs modulating 5HT activity in the treatment of anxiety. Gen. Pharmacol. 1988; 19: 347-356.